COVID-19, even in mild cases, is linked to changes in Alzheimer’s disease-related brain biomarkers comparable to four years ...

HOUSTON - Coya Therapeutics, Inc. (NASDAQ: COYA), a $109.1 million market cap biotechnology company focusing on regulatory T ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

Maryland leaders set to reveal the new design concept of the Baltimore Key Bridge. Trump orders creation of a U.S. sovereign ...

Gum disease, or periodontitis, has been linked to poorer cognitive function. Researchers believe this connection may be due ...

Able to cross the blood-brain barrier, Xenon gas seemed to perk the mice right up, which began to become particularly active ...

Alzheimer's disease (AD) is a chronic neurodegenerative disorder that is characterized by memory and physical impairment in aged individuals. microRNAs (miRNAs) are small, single-stranded noncoding ...

Xenon gas, currently used in medicine as an anesthetic and neuroprotective agent for treating brain injuries, showed ...

The recent volatility in our stock appears to be driven by misconceptions and a lack of understanding about our business and long-term strategy, but I want to reassure our investors that there have ...

IN-PEACE, which provides palliative care integrated with state-of-the-art dementia care to patients with dementia and their ...

Monoclonal antibodies, or mAbs, are important tools in medicine. These laboratory-made proteins are widely used in treatments ...